Background and Update for S1602 “A Phase III Randomized Trial to Evaluate the Influence of BCG Strain Differences and T Cell Priming with Intradermal BCG Before Intravesical Therapy for BCG-naïve High-grade Non-muscle-invasive Bladder Cancer

Eitemau Tebyg

• Background and Update for S1602 “A Phase III Randomized Trial to Evaluate the Influence of BCG Strain Differences and T Cell Priming with Intradermal BCG Before Intravesical Therapy for BCG-naïve High-grade Non-muscle-invasive Bladder Cancer”
  gan: Svatek, Robert S., et al.
  Cyhoeddwyd: (2018)
• Spectrum of Bacille Calmette‐Guerin (BCG) Infection after Intravesical BCG Immunotherapy
  gan: Omar Gonzalez, et al.
  Cyhoeddwyd: (2003)
• Systemic BCG‐osis following intravesical BCG instillation for bladder carcinoma
  gan: Liaw, Frank, et al.
  Cyhoeddwyd: (2017)
• Adaptive Immune Resistance to Intravesical BCG in Non–Muscle Invasive Bladder Cancer: Implications for Prospective BCG-Unresponsive Trials
  gan: Max Kates, et al.
  Cyhoeddwyd: (2019)
• Chest Wall Abscess Due to Mycobacterium bovis BCG after Intravesical BCG Therapy
  gan: Kanamori, Hajime, et al.
  Cyhoeddwyd: (2012)